SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., presented data at the American Epilepsy Society...

Data from nine abstracts to be presented, including first data from the EpiCom Trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, which suggests...

Data to be featured as oral and poster presentations at American Epilepsy Society 2024 Annual Meeting THOUSAND OAKS, Calif., Dec. 6, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today...

32 scientific abstracts reflect ongoing commitment to improving outcomes for people living with epilepsies Data include the use of FINTEPLA® (fenfluramine)1 oral solution in seizures associated...

SK Life Science will also host the "Prioritizing Seizure Treatments Through Real-World Patient Case Studies Symposium," an expert led panel to advance the discussion regarding the unmet need for...